How Social Support Influences Weight Health for GLP-1 Users
As the healthcare industry innovates to maximize the GLP-1 experience for patients, there appears to be an important factor that’s arguably under-discussed: loneliness.
Read Article
Thought Leadership
Explore influential and knowledgeable insights on digital care, behavior change, chronic disease management and prevention, and Omada's approach to healthcare from industry thought leaders.
-
-
Loading, please wait
Error - something went wrong!
Become an Omada
InsiderThank you!
-
3 Reasons GLP-1 Care Must Consider the Entire MSK System, Not Just Muscle Mass
Most people know that GLP-1 care can impact muscle mass, but it's important to consider the entire MSK system. Find out 3 reasons why with Omada Health.
Read Article
-
Whole-Person Well-Being Over Profits
Return on Health Framework for Realizing the Value of Virtual Care
Read Resource
-
3 Takeaways From the Downfall of Big-Name Telehealth
The primary care system is being stretched thinner than ever. Find out how the burden of primary care pushed the expansion of telehealth and explore the path forward for care innovation.
Read Article
-
Compounded GLP-1s: The Good, The Bad and The Necessary
Join Omada as we review the good, the bad, and the necessary when it comes to compounded GLP-1s and the role of virtual care in supporting GLP-1 programs.
Read Article
-
How Sleep Impacts Weight Health and Muscle Mass
Did you know that sleep impacts your weight health? Learn more with Omada about how getting a good night's rest can help you achieve your wellness goals.
Read Article
-
Don’t Forget The Beans: The Importance of Providing Culturally Relevant Dietary Advice
Culture impacts many things including diet and lifestyle. Omada coaches are trained to provide culturally appropriate recommendations for healthy change.
Read Article
-
Omada Health’s Guide to GLP-1s | Q3 - Q4 2024
Omada drills into emerging details of the GLP-1 experience, including compounded GLP-1s, how to manage the drug’s impact on body composition, & ways to assess the value of virtual companion programs.
Read Article
-
Using AI to Strengthen Human Relationships: Q&A with Terry Miller, VP of Machine Learning, AI and Data Science Strategy
Q&A with Terry Miller, VP of Machine Learning, AI and Data Science Strategy
Read Article
-
What Divides Patients and Providers on GLP-1 Adherence
With the emergence of GLP-1s, there is a divide between patient perception of the medication and how clinical science views it. Find out more with Omada.
Read Article
-
Omada Health's Journey with Artificial Intelligence
How Data Science and AI learnings surprised us, taught us, and propelled us forward.
Read Article
-
How to Combat Muscle Loss While Taking GLP-1s
A side-effect of taking GLP-1s is a loss of muscle mass. Julie Mulcahy, PT, DPT, CAPP OB explores how to combat this with resistance exercises.
Read Article
-
The Science Behind Dieting, and Why it Doesn’t Work
Lisa McCormick, FNP-BC, RD, CDCES explores the science behind dieting and why it doesn't work. Find out more about sustainable weight loss!
Read Article
-
Omada Health’s Guide to GLP-1 Weight Loss | Quantity vs. Quality
Omada delivers GLP-1 FAQs focusing on weight loss quantity vs. quality with timely data and insights for employers, health plans and benefit consultants.
Read Article
-
GLP-1 Demand Spotlights Existing Inequities in Obesity Care
Obesity is one of the clearest case studies of health disparities that exist in the U.S., having the biggest impact on Black and Hispanic adults, low-income populations, and people covered by Medicaid
Read Article
-
Become an Omada Insider
Subscribe -
Why Accreditations are Essential in Digital Health
Digital health is rapidly growing and promises to make healthcare more accessible and convenient for patients. However, not all digital healthcare providers are created equally.
Read Article
-
How Essentia Health Achieves High Enrollment and Engagement in Its Virtual Diabetes Care Partnerships
Omada Health Customer Case Study: Learn how Essentia Health surpassed enrollment and engagement goals in its diabetes programs, and how they market virtual care solutions to their population.
Read Article
-
When Will GLP-1 Prices Drop?
GLP-1 agonist medications have had impressive initial outcomes. However, the long-term effects on a patient’s health beyond the trial timelines and on the costs to the healthcare system are uncertain.
Read Article
-
528.4 Billion Reasons Medication Optimization Matters
Medication optimization ensures that the right patient gets the right medication at the right time. Unfortunately it’s not always feasible.
Read Article
-
Disparities in the Diabetes Journey for Women: A Call for Health Equity
Over 15 million women in the U.S. have diabetes. Diabetes impacts women more severely than men and women face added hurdles when managing the disease. It’s time we pay attention.
Read Resource
-
Loading More...
